updates on our latest developments
press releases
Be among the first to get updates on the latest developments at Hummingbird Diagnostics by joining our mailing list for journalists.
Contact Hummingbird Diagnostics: info@hb-dx.com
- 12.01.2026
- Hummingbird Diagnostics Names Vincent Lozada Chief Executive Officer
- 16.12.2025
- Hummingbird Diagnostics Publishes Study on RNA Biomarker Methylation in Liquid Biopsies
- 06.03.2024
- Hummingbird Diagnostics Announces Publication Evaluating miR-Blood's Small RNA Expression Dataset Capabilities in Nature’s Scientific Data
- 23.01.2024
- Hummingbird Diagnostics Announces Initiation of Patient Recruitment for Clinical Study Evaluating miLungDx as a Novel Diagnostic Test for Early-stage Lung Cancer
- 25.10.2023
- Hummingbird Diagnostics GmbH to Unveil Pioneering Alzheimer's Disease Biomarker Research at CTAD Conference
- 11.07.2023
- Hummingbird Diagnostics Announces Publication of miLung Small RNA-Based Blood Test for Early Detection of Lung Cancer in the Journal of Thoracic Oncology
- 31.05.2023
- Hummingbird Diagnostics to Present Poster on miLung Small RNA-Based Blood Test at the ASCO 2023 Annual Meeting
- 23.06.2022
- Hummingbird Diagnostics Publishes Study of miRisk as a Predictor of Immunotherapy Efficacy in Advanced-Stage NSCLC
Disclaimer
The press releases of Hummingbird Diagnostics GmbH are for informational purposes only and may contain forward-looking statements subject to risks and uncertainties; actual results may differ materially. The information does not constitute medical, legal, or financial advice. References to partners, institutions, or funding sources are provided for transparency only and do not imply endorsement. Hummingbird Diagnostics GmbH assumes no responsibility for the accuracy, completeness, or timeliness of the information provided and undertakes no obligation to update or revise any statements.
our recent publications
publications
Learn more about genomic biomarkers and read our latest publications.
Are you a scientist interested in cooperative research and publication projects? Send an email to info@hb-dx.com.
Nanopore based RNA methylation profiling of a circulating lung cancer biomarker
Sanchez-Delgado M, Frank M, Šišmiš T, Kahraman M, Daniel-Moreno A, et al.
Commun Med 2025
Early detection of Alzheimer’s disease using small RNAs. Results from the EPAD cohort
Sikosek T, Heuvelman M, Mika J, Kahraman M, Jehn J, et al.
JPAD 2025
TransfoRNA: Navigating the Uncertainties of Small RNA Annotation with an Adaptive Machine Learning Strategy
Taha Y, Jehn J, Kahraman M, Frank M, Heuvelman M, et al.
bioRxiv 2024
miR-Blood – a small RNA atlas of human blood components
Jehn J, Trudzinski F, Horos R, Schenz J, Uhle F, et al.
Scientific Data 2024
open to new approaches
meet us
events
Take the opportunity to meet us and discuss your requests and projects.
Feel free to contact us if you have any questions or if you would like to arrange a meeting info@hb-dx.com.